대한부인종양학회

최신 논문

총 게시글 : 156

Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer 2023-06-29 VIEW : 29
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors 2023-06-29 VIEW : 32
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study 2023-06-29 VIEW : 14
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts 2023-03-29 VIEW : 91
Preoperative brachytherapy for early-stage cervical cancer: Systematic review and meta-analysis 2023-03-29 VIEW : 38
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial 2023-03-29 VIEW : 35
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial 2023-03-29 VIEW : 34
Cancer Treatment-Related Ovarian Dysfunction in Women of Childbearing Potential: Management and Fertility Preservation Options 2023-03-29 VIEW : 47
NItrogen-based bisphosphonate use ad ovarian cancer risk in women aged 50 years and older 2022-10-13 VIEW : 87
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial 2022-06-28 VIEW : 79
Survival with Cemiplimab in Recurrent Cervical Cancer 2022-03-31 VIEW : 79
Association of Germiline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data 2022-03-30 VIEW : 61
SUCCOR cone study: conization before radical hysterectomy 2022-02-14 VIEW : 79
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer 2021-12-20 VIEW : 47
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial 2021-12-20 VIEW : 34

1
2
3
4
5
6
7
8
9
10
11